[144] Natera, Inc. SEC Filing

Rhea-AI Filing Summary

Natera, Inc. insider filing (Form 144) reports a proposed sale of 5,079 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $845,794.70 and approximately 137,248,106 shares outstanding. The shares to be sold were originally acquired as restricted stock on 01/21/2022 from the issuer and payment is recorded as Not Applicable.

The filing also discloses multiple prior sales by the same person in the past three months: 5,807 shares on 08/01/2025 for $771,656.23; 6,092 shares on 07/28/2025 for $851,712.16; 1,622 shares on 07/21/2025 for $225,928.38; and 5,343 shares on 07/01/2025 for $889,777.80. The filer certifies no undisclosed material adverse information and complies with Rule 144 disclosure requirements.

Positive

• Clear compliance with Rule 144 including broker, share amounts, and acquisition details
• Detailed prior sales disclosed for the past three months with dates and gross proceeds, enhancing transparency

Negative

• Multiple recent insider sales (totaling 18,864 shares in three months) could be perceived negatively by some investors
• Aggregate market value of proposed sale ($845,794.70) represents insider liquidity that may warrant monitoring for potential signaling

Insights

Securities Analyst

TL;DR Insider intends to sell a small block of shares after multiple recent sales; disclosure is routine and compliant.

The filing shows a proposed sale of 5,079 restricted shares via a broker and lists four recent dispositions totaling 18,864 shares in the prior three months with combined gross proceeds exceeding $2.7 million. From a market-impact perspective this level of insider selling appears to be execution of planned liquidity rather than a one-time large, blocking disposition. The disclosure is timely and meets Rule 144 requirements, allowing investors to observe insider liquidity events without implying undisclosed issues.

Corporate Governance Expert

TL;DR Multiple recent insider sales increase monitoring needs but filing itself is a standard, compliant disclosure.

The document documents acquisition as restricted stock and subsequent sales over several dates, indicating routine monetization of holdings. The signer affirms absence of undisclosed material adverse information, which is customary. Governance teams should note frequency and scale of sales for context around insider alignment, but the filing contains required representations and broker details, supporting regulatory transparency.

09/02/2025 - 04:16 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5079	845794.70	137248106	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2022	Restricted Stock	Issuer			5079	01/21/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
STEVEN L CHAPMAN 13011 McCallen Pass Building A Suite 100 Austin TX 78753	Common	08/01/2025	5807	771656.23
STEVEN L CHAPMAN 13011 McCallen Pass Building A Suite 100 Austin TX 78753	Common	07/28/2025	6092	851712.16
STEVEN L CHAPMAN 13011 McCallen Pass Building A Suite 100 Austin TX 78753	Common	07/21/2025	1622	225928.38
STEVEN L CHAPMAN 13011 McCallen Pass Building A Suite 100 Austin TX 78753	Common	07/01/2025	5343	889777.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for NTRA disclose?

The filing discloses a proposed sale of 5,079 common shares via Morgan Stanley Smith Barney with an aggregate market value of $845,794.70 on NASDAQ.

When were the shares to be sold originally acquired?

The shares were acquired as restricted stock on 01/21/2022 from the issuer.

Has the filer sold other NTRA shares recently?

Yes. The filer sold 5,807 shares on 08/01/2025, 6,092 on 07/28/2025, 1,622 on 07/21/2025, and 5,343 on 07/01/2025 with listed gross proceeds.

Through which broker will the proposed sale be executed?

The proposed sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.

Does the filer assert any undisclosed material information about Natera?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.